Merck & Co., Inc.
USD114.80
-0.85 (-0.73%)
CEO
Robert Davis
IPO Date
1978-01-13
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
US
Open
$115.44
Prev. Close
$115.65
Day Low
$114.73
Day High
$117.33
52W Low
$76.66
52W High
$125.14
Market Cap
$283.54B
Volume
6.05M
| 14.7 |
| 31 Dec 2023 | FY | 73.2% | 0.6% | 1.0% | 0.3% | 0.97 | 1.25 | 778.7 |
| 31 Dec 2022 | FY | 70.6% | 24.5% | 31.6% | 13.3% | 0.67 | 1.47 | 19.3 |
| 31 Dec 2021 | FY | 72.0% | 26.8% | 34.2% | 12.3% | 0.87 | 1.27 | 14.9 |
| 31 Dec 2020 | FY | 67.7% | 14.7% | 27.9% | 7.7% | 1.26 | 1.02 | 27.9 |
| 31 Dec 2019 | FY | 69.9% | 21.0% | 38.0% | 11.7% | 1.02 | 1.24 | 22.4 |
| 31 Dec 2018 | FY | 68.1% | 14.7% | 23.3% | 7.5% | 0.94 | 1.17 | 30.4 |
| 31 Dec 2017 | FY | 68.2% | 6.4% | 7.5% | 2.9% | 0.71 | 1.33 | 56.4 |
| 31 Dec 2016 | FY | 65.1% | 14.3% | 14.2% | 6.0% | 0.62 | 1.78 | 27.1 |
| 9.1 |
| 30 Jun 2025 | Q2 | 77.5% | 28.0% | 9.0% | 3.8% | 0.72 | 1.42 | 11.2 |
| 31 Mar 2025 | Q1 | 78.0% | 32.7% | 10.5% | 4.4% | 0.72 | 1.41 | 11.1 |
| 31 Dec 2024 | Q4 | 94.1% | 24.0% | 8.1% | 3.2% | 0.80 | 1.36 | 16.9 |
| 30 Sept 2024 | Q3 | 75.5% | 19.0% | 7.1% | 2.7% | 0.86 | 1.36 | 22.9 |
| 30 Jun 2024 | Q2 | 73.4% | 33.8% | 12.5% | 4.8% | 0.87 | 1.47 | 14.9 |
| 31 Mar 2024 | Q1 | 77.6% | 30.2% | 11.8% | 4.5% | 0.85 | 1.25 | 17.4 |
| 31 Dec 2023 | Q4 | 73.3% | -8.4% | -3.3% | -1.1% | 0.94 | 1.25 | -56.8 |
| 30 Sept 2023 | Q3 | 73.3% | 29.7% | 11.5% | 4.4% | 0.85 | 1.38 | 13.8 |